The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials.
Xinyu TaoZeya YanJiahao MengWei WangQiling DaiQiufeng ZhouZhifeng WangZhong WangPublished in: The journal of headache and pain (2022)
Atogepant has shown good efficacy and safety in the prophylactic treatment of migraine, and further studies are expected.